insights

UPDATED with Registration Link! CITI Program Webinar on Managing Risk by Contract Presented by Katherine Leibowitz on October 5, 2023

We are pleased to announce that Katherine Leibowitz will be presenting a webinar on Managing Risk by Contract- Sponsor Perspectives on Clinical Trial Agreements on October 5, 2023, at 2 p.m. EST.

This hour-long webinar is free of charge.  We will receive the registration link from CITI Program 1-2 weeks before the event and will post it on this page, so please check back.

The webinar will be chock-full of clinical trial lawyers’ favorite CTA topics, including:

  • Study data, source records and specimens
  • Impact of digital health technologies (DHTs), decentralized clinical trials (DCTs) and cybersecurity concerns on CTA negotiations
  • Subject injury, indemnification and insurance
  • Best practices for effective CTA negotiations
  • Live Q&A at the end

The Collaborative Institutional Training Initiative (CITI Program) is well-known in the IRB world, as many IRBs require their investigators and study personnel to complete specific CITI training.  CITI is “dedicated to serving the training needs of colleges and universities, healthcare institutions, technology and research organizations, and governmental agencies, as they foster integrity and professional advancement of their learners.”

UPDATED:  Click the following link to register.  Please submit your questions in advance via the registration link.  Katherine will answer these during the live Q&A.

Click here to register for the CITI Program Webinar

We hope to see you there!

This contents of this alert should not be construed as legal advice or a legal opinion on any specific facts or circumstances. This content is not intended to and does not, by its receipt, create an attorney-client relationship. The contents are intended for general informational purposes only. We urge you to consult your attorney about the specific situation and any legal questions you may have. Attorney advertising in some jurisdictions. © 2024 Leibowitz Law. All rights reserved. “Leibowitz Law” is a trade name of Leibowitz LLC.

Want to receive notifications?

To be notified when we post new Insights, please sign up for our email list. As industry thought leaders, Leibowitz Law Insights address developing issues at the intersection of law, regulation, technology and life sciences…

SIGN UP FOR OUR LATEST INSIGHTS